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INTRODUCTION
Moraxella osloensis, an oxidase-positive, nonmotile, asaccha-
rolytic, aerobic gram-negative coccobacilli is a part of the
normal flora of the human respiratory tract (1, 2). The organ-
ism is difficult to identify because of presence of several other
species with similar phenotypic characteristics. Species of some
glucose non-fermenting gram-negative bacilli are not only
difficult to identify by routine methods, but also the clinical
significance is not always easy to interpret. Clinical signifi-
cance of M. osloensis isolates even from normally sterile site
may be difficult to determine, because the organism rarely
cause invasive infections. We report three cases of M. osloen-
sis meningitis in two children with no known underlying
disease and in one adult cancer patient.
CASE REPORTS
Case 1
A 4-yr-old girl was admitted to the Pediatric Department
on May 27, 2002, with a 1-day history of headache, fever
(38.1℃), abdominal pain, and vomiting (Table 1). Her past
medical history was unremarkable and she was up-to-date
with her immunizations. Her physical and neurological exam-
inations were unremarkable.
Laboratory tests revealed a peripheral white blood cell (WBC)
count of 19,800/mL (91% neutrophils), a hemoglobin level of
11.6 g/dL, and a platelet count of 356,000/mL. Cerebrospinal
fluid (CSF) had a hazy appearance with an increased WBC
count of 890/mL (99% neutrophils), but no significant change
in glucose concentration of 78 mg/dL, and a protein level of
31 mg/dL (Table 2). Routine blood chemistry results were
within the reference range. A chest radiograph was normal.
The patient was treated with cefotaxime and ampicillin
for 1 week. The patient became afebrile after 2 days of treat-
ment, and her other symptoms also improved. The CSF anal-
ysis showed a decreased WBC count to 9/mL from 890/mL at
hospital day 3. She was discharged on 9th hospital day with-
out complications.
Case 2
A 15-yr-old boy was admitted to the Neurology Depart-
ment on May 18, 2005, with a 3-day history of headache and
2 days of generalized petechiae, nausea, and vomiting (Table
1). His past medical history was unremarkable. On admis-
sion, his oral temperature was 36.9℃, heart rate was 93 beats/
min, and blood pressure was 125/82 mmHg. He was alert
and complained about neck stiffness. There were no motor
or sensory deficits, and the rest of his physical examination
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Three Cases of Moraxella osloensis Meningitis: A Difficult Experience
in Species Identification and Determination of Clinical Significance
We had three cases of Moraxella osloensis meningitis. The species identification
was impossible by conventional and commercial phenotypic tests. However, we
could identify the species using the 16S rRNA gene sequencing. Determination of
clinical significance was difficult in one patient. All three patients recovered by appro-
priate antimicrobial therapy.  
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A laboratory investigation at the time of admission reve-
aled a peripheral WBC count of 30,290/mL (96% neutro-
phils), a hemoglobin level of 15.4 g/dL, and a platelet count
of 151,000/mL. CSF had a cloudy appearance with an increas-
ed protein concentration of 575 mg/dL, and a WBC count
of 35,500/mL (90% neutrophils) and a decreased glucose con-
centration of 10 mg/dL (Table 2). Routine blood chemistry
results were within the reference range. A chest radiograph
was normal. 
The patient was treated with ceftazidime and netilmicin
for 2 weeks. His clinical condition was improved after 3 days,
and the CSF analysis showed a decreased WBC count and pro-
tein concentration to 4,150/mL and 90 mg/dL from 35,500/mL
and 575 mg/dL, respectively. On 13th hospital day, the CSF
WBC count decreased to 130/mL, and the patient was dis-
charged without complications on 18th hospital day.
Case 3
An 81-yr-old man with a known history of pancreatic can-
cer (March, 2004) and liver cirrhosis due to hepatitis C virus
infection (June, 2004) was admitted to the Emergency Depart-
ment on June 6, 2005, with drowsy mental status for one
day. On admission, he had icteric sclera (Table 1). 
Laboratory investigation revealed a peripheral WBC count
of 6,950/mL (73% neutrophils), a hemoglobin level of 12.8
g/dL, and a platelet count of 60,000/mL. CSF was clear with
a protein level of 38 mg/dL, a slightly increased WBC count
of 9/mL, and a glucose concentration of 76 mg/dL (Table 2).
Routine blood chemistry showed increased blood urea nitro-
gen/creatinine of 41.8/2.2 mg/dL, ammonia of 287 mg/dL
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Case No. Age/sex Underlying disease Outcome Treatment Symptoms and signs
1 (3944144) 4/F Headache, fever, abdominal pain, vomiting Not found Cefotaxime+ampicillin, 1 week Recovered
2 (4345094) 15/M Headache, petechiae, neck stiffness Not found Ceftazidime+netilmicin, 2 weeks Recovered
3 (2642844) 81/M Drowsy mental state Pancreatic cancer, Cefotaxime, 1 week Recovered
liver cirrhosis
Table 1. Characteristics of patients with Moraxella osloensis meningitis 
Case No. On admission Discharge Hospital day 3 Lab. test
1 (3944144) Peripheral blood
WBC (/mL) (Neutrophil %) 19,800 (91%) 8,230 (38%) Not tested
CRP (mg/dL) 0.34 Not tested Not tested
CSF
WBC (/mL) (Neutrophil %) 890 (99%) 9 Not tested
Protein (mg/dL) 31 25 Not tested
Gram stained smear Negative for bacteria Negative for bacteria  Not tested
Culture Some M. osloensis No growth  Not tested
Blood culture No growth
2 (4345094) Peripheral blood
WBC (/mL) (Neutrophil %) 30,290 (96%) 7,710 (84%) 7,440 (77%)
CRP (mg/dL) 33.1 Not tested 0.66
CSF
WBC (/mL) (Neutrophil %) 35,500 (90%) 4,150 (94%) 130 (6%)
Protein (mg/dL) 575 90  56
Gram stained smear Many Gram-neg coccobacilli Negative for bacteria  Negative for bacteria 
Culture Many M. osloensis No growth No growth
Blood culture No growth
3 (2642844) Peripheral blood
WBC (/mL) (Neutrophil %) 6,950 (78%) 7,630 (84%) 4,910 (55%)
CRP (mg/dL) Not tested Not tested Not tested
CSF
WBC (/mL) (Neutrophil %) 9 0 Not tested
Protein (mg/dL) 38 41 Not tested
Gram stained smear Negative for bacteria  Negative for bacteria  Not tested
Culture Few M. osloensis No growth Not tested
Blood culture No growth
Table 2. Laboratory test results obtained during the course of meningitis
WBC, white blood cell; CRP, C-reactive protein; CSF, cerebrospinal fluid.  and total bilirubin of 3.1 mg/dL. The other test results were
unremarkable.
The patient was treated with cefotaxime for 1 week. On
hospital day 3, the CSF WBC count decreased to 0/mL. He
was managed conservatively and was discharged 18th hos-
pital day without complications.
Microbiologic tests
In case no. 2 many gram-negative coccobacilli were detect-
ed on smear of a CSF. In cases no. 1 and no. 3, bacteria were
not detected on smears. The culture of CSF specimens from
case no. 2 on blood and chocolate agar plates yielded heavy
growth of medium sized (0.5-1 mm) grayish colonies after
overnight CO2 incubation. In case No. 1, moderate growth
was observed after overnight CO2 incubation. In case no. 3,
several colonies were detected after 2 days incubation. The
Gram-stained smear of colonies revealed gram-negative coc-
cobacilli in all three cases. The isolates were oxidase positive
and did not oxidize glucose. The correct species identification
was not achieved not only by the conventional biochemical
tests, but also by the API ID 32 GN system (profile 00000-
000002), and Vitek2 GN system (bioMerieux, Marcy l’Etoile,
France), but suggested Moraxella spp. 16S rRNA gene sequenc-
ing (3) identified all three isolates as M. osloensis (≥98% agree-
ment with GenBank accession no. AF005190) (Table 3). The
antimicrobial susceptibility test performed by the disk dif-
fusion method (4) showed all three isolates were susceptible
to ampicillin, cephalothin, cefoxitin, cefotaxime, ceftazidime,
cefepime, levofloxacin, imipenem, amikacin, netilmicin, and
gentamicin.
DISCUSSION
Members of the genus Moraxella are oxidase-positive, non-
motile, and asaccharolytic coccobacilli. Genus Moraxella con-
sists of seven species, M. atlantae, M. canis, M. catarrhalis, M.
lacunata, M. lincolnii, M. nonliquefaciens, and M. osloensis (1).
Graham et al. (5) reported that M. osloensis was common and
the most frequent isolate from blood and CSF among clini-
cal isolates of Moraxella spp. It has been rarely reported to
cause local or invasive infections, including osteomyelitis,
meningitis, bacteremia, pneumonia, and catheter associated
infection (6-11).
A PubMed search yielded four published cases of M. osloen-
sis meningitis. Two patients had known predisposing factors
for infection such as cerebrospinal fluid shunt and C8 com-
plement deficiency, but the remaining two patients had no
known underlying disease (12). The children in case 1 and 2
had no underlying diseases. These children had typical menin-
gitis symptoms such as headache, neck stiffness, nausea, and
vomiting, an elevated WBC count, and increased protein in
CSF analysis. In case No. 1, we could not totally exclude the
coexistence of viral and bacterial meningitis because we did
not test virus culture nor virus antigen assay. The adult pati-
ent (case No. 3) had underlying pancreatic cancer and liver
cirrhosis. As this patient had drowsy mental status on admis-
sion, CSF examination and culture were performed to rule out
meningitis. A possible explanation of low CSF WBC count
was due to lower peripheral WBC count resulting from var-
ious cytotoxic therapies. The clinical diagnosis of this patient
was hepatic encephalopathy because of high blood ammonia
and high total bilirubin level. This patient was also diagnos-
ed as bacterial meningitis because of M. osloensis growth from
CSF. With appropriate antimicrobial agents’ treatment, peri-
pheral blood WBC count and CSF WBC count decreased.
Identification of an unusual bacterial isolate is a very dif-
ficult problem in a clinical microbiology laboratory. Moraxel-
la spp. grows well in capnophilic conditions, but grows slow-
ly in ambient air which may lead to delays in diagnosis. Com-
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*Data from references 1 and 2.
NT, not tested.
Test
M.
osloen-
sis*
M.
atlan-
tae*
Case 
No. 1
YMC-02-
5-C696
Case 
No. 2 
YMC-05-
5-C280
Case 
No. 3
YMC-05-
6-C96
Gram-negative Yes Yes Yes Yes Yes
coccobacilli
Oxidase + + + + +
Motility -- - - -
Indole -- - - -
Catalase + + + + +
Urease -- - - -
Growth on V V ---
MacConkey agar
Phenylalanine V -- - -
deaminase
Acid from
Glucose -- - - -
Sucrose -- - - -
Lactose -- - - -
Mannitol -- - - -
Nitrate reduction V -- - -
Vitek system Nonferment- NT Moraxella
ing gram- group 
negative 50%
bacillus 
90%
Vitek NHI NT NT Neisseria
meningitidis
96%
API 32 GN NT Myroides  NT 
spp. 
90%
16S rRNA gene  M. M. M.
sequencing osloensis osloensis osloensis
(>99%) (>98%) (>99%)
Table 3. Comparison of cultural and biochemical characteristics
of Moraxella isolatesmercially available identification kit systems are sometimes
unable to reliably identify unusual microorganisms. Using
conventional biochemical tests and two commercial identi-
fication kits, we were able to infer the genus Moraxella. How-
ever, we could not definitively identify the species because
the results of various biochemical tests are similar among the
seven Moraxella spp. 
Only with 16S rRNA gene sequence analysis, we were able
to definitively identify the isolates as M. osloensis (3). This new
method consists of PCR amplification and sequencing of the
16S rRNA gene in bacteria, followed by a comparison of the
16S rRNA gene sequence with those registered in GenBank.
The case no. 1 and no. 3 isolates matched with more than
99% and the case no. 2 isolate matched with more than 98%
agreement with M. osloensis. 
M. osloensis is usually susceptible to penicillin G, cephalo-
sporins, and aminoglycosides (5, 13). There are a few reports
that treatment with penicillin G and ampicillin for M. osloen-
sis bacteremia and meningitis has been successful. All three
strains were susceptible to majority of antimicrobial agents,
including ampicillin, cephalothin, cefotaxime, amikacin, lev-
ofloxacin, and imipenem. All patients were treated success-
fully with third-generation cephalosporins alone or in com-
bination with netilmicin. 
In conclusion, although M. osloensis meningitis is rare it
may cause severe CNS infection in children and in adult can-
cer patient. We were able to definitely identify the species of
the isolates only by using 16S rRNA gene sequencing. All
three patients recovered by appropriate antimicrobial therapy.
REFERENCES
1. Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG. Acine-
tobacter, Achromobacter, Chryseobacterium, Moraxella, and other
nonfermentative gram-negative rods. In: Murray PR, Baron EJ, Jor-
gensen JH, Pfaller MA, eds, Manual of Clinical Microbiology. Wash-
ington: American Society for Microbiology 2003; 754-7.
2. Weyant RS, Moss CW, Weaver RE, Hollis DG, Jordan JG, Cook
EC, Daneshvar MI. Identification of unusual pathogenic gram-neg-
ative aerobic and facultatively anaerobic bacteria. Baltimore: Williams
& Wilkins 1995; 390-405.
3. Clarridge JE 3rd. Impact of 16S rRNA gene sequence analysis for iden-
tification of bacteria on clinical microbiology and infectious diseases.
Clin Microbiol Rev 2004; 17: 840-62.
4. NCCLS. Performance Standards for Antimicrobial Susceptibility
Testing; Twelfth Informational Supplement. Document M100-S12.
Wayne, Pa: NCCLS, 2002.
5. Graham DR, Band JD, Thornsberry C, Hollis DG, Weaver RE. Infec-
tions caused by Moraxella, Moraxella urethralis, Moraxella-like
groups M-5 and M-6, and Kingella kingae in the United States, 1953-
1980. Rev Infect Dis 1990; 12: 423-31.
6. Sugarman B, Clarridge J. Osteomyelitis caused by Moraxella osloen-
sis. J Clin Microbiol 1982; 15: 1148-9.
7. Berger U, Kreissel M. Menigitis due to Moraxella osloensis. Infec-
tion 1974; 2: 166-8.
8. Fritsche D, Karte H, del Solar E. Moraxella osloensis as pathogen
in septicemia. Infection 1976; 4: 53-4.
9. Vuori-Holopainen E, Salo E, Saxen H, Vaara M, Tarkka E, Peltola
H. Clinical ‘‘pneumococcal pneumonia’’ due to Moraxella osloen-
sis: case report and a review. Scand J Infect Dis 2001; 33: 625-7.
10. Han XY, Tarrand JJ. Moraxella osloensis blood and catheter infec-
tions during anticancer chemotherapy: clinical and microbiologic
studies of 10 cases. Am J Clin Pathol 2004; 121: 581-7.
11. Buchman AL, Pickett MJ, Mann L, Ament ME. Central venous
catheter infection caused by Moraxella osloensis in a patient receiv-
ing home parenteral nutrition. Diagn Microbiol Infect Dis 1993; 17:
163-6.
12. Shah SS, Ruth A, Coffin SE. Infection due to Moraxella osloensis:
case report and review of the literature. Clin Infect Dis 2000; 30:
179-81.
13. Rosenthal SL, Freundlich LF, Gilardi GL, Clodomar FY. In vitro
antibiotic sensitivity of Moraxella species. Chemotherapy 1978; 24:
360-3.
504 K.H. Roh, C.K. Kim, E. Koh, et al.